Stock Price
12.56
Daily Change
-0.02 -0.16%
Monthly
-12.72%
Yearly
-70.38%
Q3 Forecast
12.48

Tandem Diabetes Care reported $125.85M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.



Financials
Assets USD 875.74M
Cost of Sales USD 114.82M
Current Assets USD 614.82M
Debt USD 449.01M
EBIT USD -31.86M
EBITDA USD -1.85M
Employees 2.65K
Interest Income USD 4.19M
Loan Capital USD 309.15M
Net Income USD -52.4M
Operating Expenses USD 272.54M
Operating Profit USD -31.86M
Pre-Tax Profit USD -57.72M
Sales Revenues USD 240.68M
Stock USD 142.57M
Trade Creditors USD 55.84M
Trade Debtors USD 128.44M

Gross Profit On Sales Change Date
Abbott USD 5.87B 50M Jun/2025
Align Technology USD 708.12M 28.01M Jun/2025
AtriCure USD 101.48M 8.85M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Boston Scientific USD 3.42B 228M Jun/2025
Cooper Companies USD 692M 12.9M Jul/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Globus Medical USD 1.21B 809.01M Jun/2025
ICU Medical USD 208.06M 2.04M Jun/2025
Insulet USD 452.2M 43.2M Jun/2025
Integra LifeSciences USD 209.33M 5.81M Jun/2025
Intuitive Surgical USD 1.62B 160.2M Jun/2025
J&J USD 14.6B 816M Mar/2025
Masimo USD 233.3M 700K Jun/2025
Medtronic USD 5.12B 695M Jul/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Stryker USD 3.84B 30M Jun/2025
Tandem Diabetes Care USD 125.85M 7.45M Jun/2025
Teleflex USD 431.08M 41.65M Jun/2025
Zimmer Biomet Holdings USD 1.32B 34.8M Jun/2025